Double-blind, crossover, comparison of olopatadine and cetirizine versus placebo: Suppressive effects on skin response to histamine iontophoresis

Journal of Dermatology

Volumn 32, Issue 1, 2005, Pages 58-61

  Morita, Eishin ^a   Matsuo, Hiroaki ^a   Zhang, Yan ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Cetirizine; Histamine; Iontophoresis; Olopatadine; Wheal and flare

Indexed keywords

CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; OLOPATADINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EQUIPMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; IONTOPHORESIS; MALE; NORMAL HUMAN; PROVOCATION TEST; PRURITUS; SKIN MANIFESTATION; URTICARIA; VISUAL ANALOG SCALE;

EID: 14644396602     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00716.x     Document Type: Article

References (6)

1. Simons FE, McMillan JL, Simons KJ: A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects, J Allergy Clin Immunol, 86: 540-547, 1990.
2. Simons FE, Silver NA, Gu X, Simons KJ: Clinical pharmacology of H1-antihistamines in the skin, J Allergy Clin Immunol, 110: 777-783, 2002.
3. Grant JA, Danielson L, Rihoux JP, DeVos C: A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: Suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects, Allergy, 54: 700-707, 1999.
4. Leroy T, Tasset C, Valentin B, Van Neste D: Comparison of the effects of cetirizine and ebastine on the skin response to histamine iontophoresis monitored with laser Doppler flowmetry, Dermatology, 197: 146-151, 1998.
5. Furue M, Terao H, Koga T: Effects of cetirizine and epinastine on the skin response to histamine iontophoresis, J Dermatol Sci, 25: 59-63, 2001.
6. Ohmori K, Hayashi K, Kaise T, et al: Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug, Jpn J Pharmacol, 88: 379-397, 2002.